Terns Pharmaceuticals (TERN) Competitors $6.17 -0.38 (-5.80%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends TERN vs. AQST, ICPT, INZY, ENTA, ENZ, AMPH, EVO, AKRO, CNTA, and HRMYShould you be buying Terns Pharmaceuticals stock or one of its competitors? The main competitors of Terns Pharmaceuticals include Aquestive Therapeutics (AQST), Intercept Pharmaceuticals (ICPT), Inozyme Pharma (INZY), Enanta Pharmaceuticals (ENTA), Enzo Biochem (ENZ), Amphastar Pharmaceuticals (AMPH), Evotec (EVO), Akero Therapeutics (AKRO), Centessa Pharmaceuticals (CNTA), and Harmony Biosciences (HRMY). These companies are all part of the "medical" sector. Terns Pharmaceuticals vs. Aquestive Therapeutics Intercept Pharmaceuticals Inozyme Pharma Enanta Pharmaceuticals Enzo Biochem Amphastar Pharmaceuticals Evotec Akero Therapeutics Centessa Pharmaceuticals Harmony Biosciences Terns Pharmaceuticals (NASDAQ:TERN) and Aquestive Therapeutics (NASDAQ:AQST) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation. Is TERN or AQST more profitable? Terns Pharmaceuticals has a net margin of 0.00% compared to Aquestive Therapeutics' net margin of -59.75%. Aquestive Therapeutics' return on equity of 0.00% beat Terns Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Terns PharmaceuticalsN/A -32.76% -31.33% Aquestive Therapeutics -59.75%N/A -33.96% Does the MarketBeat Community believe in TERN or AQST? Aquestive Therapeutics received 170 more outperform votes than Terns Pharmaceuticals when rated by MarketBeat users. Likewise, 67.96% of users gave Aquestive Therapeutics an outperform vote while only 60.61% of users gave Terns Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTerns PharmaceuticalsOutperform Votes4060.61% Underperform Votes2639.39% Aquestive TherapeuticsOutperform Votes21067.96% Underperform Votes9932.04% Which has stronger valuation & earnings, TERN or AQST? Aquestive Therapeutics has higher revenue and earnings than Terns Pharmaceuticals. Aquestive Therapeutics is trading at a lower price-to-earnings ratio than Terns Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTerns Pharmaceuticals$1M524.08-$90.21M-$1.18-5.23Aquestive Therapeutics$50.58M8.00-$7.87M-$0.45-9.87 Do insiders & institutionals believe in TERN or AQST? 98.3% of Terns Pharmaceuticals shares are held by institutional investors. Comparatively, 32.5% of Aquestive Therapeutics shares are held by institutional investors. 15.1% of Terns Pharmaceuticals shares are held by insiders. Comparatively, 7.9% of Aquestive Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts rate TERN or AQST? Terns Pharmaceuticals presently has a consensus target price of $27.25, suggesting a potential upside of 341.65%. Aquestive Therapeutics has a consensus target price of $9.80, suggesting a potential upside of 120.72%. Given Terns Pharmaceuticals' higher possible upside, equities analysts plainly believe Terns Pharmaceuticals is more favorable than Aquestive Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Terns Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Aquestive Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Does the media favor TERN or AQST? In the previous week, Terns Pharmaceuticals had 12 more articles in the media than Aquestive Therapeutics. MarketBeat recorded 17 mentions for Terns Pharmaceuticals and 5 mentions for Aquestive Therapeutics. Terns Pharmaceuticals' average media sentiment score of 1.15 beat Aquestive Therapeutics' score of 0.65 indicating that Terns Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Terns Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aquestive Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, TERN or AQST? Terns Pharmaceuticals has a beta of -0.32, meaning that its stock price is 132% less volatile than the S&P 500. Comparatively, Aquestive Therapeutics has a beta of 2.82, meaning that its stock price is 182% more volatile than the S&P 500. SummaryTerns Pharmaceuticals and Aquestive Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TERN vs. The Competition Export to ExcelMetricTerns PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$524.07M$6.53B$5.15B$8.74BDividend YieldN/A8.16%5.18%4.08%P/E Ratio-5.234.7865.5913.48Price / Sales524.08377.381,278.7587.67Price / CashN/A51.2039.7035.24Price / Book1.449.686.475.93Net Income-$90.21M$154.43M$119.73M$225.73M7 Day Performance-15.48%-9.46%-5.13%-1.34%1 Month Performance-17.73%-7.27%-2.71%1.15%1 Year Performance66.31%28.13%31.08%24.02% Terns Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TERNTerns Pharmaceuticals4.378 of 5 stars$6.17-5.8%$27.25+341.7%+69.0%$524.07M$1M-5.2340Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsAQSTAquestive Therapeutics1.9868 of 5 stars$4.51-1.3%N/A+158.1%$411.22M$50.58M-10.02160Short Interest ↓ICPTIntercept Pharmaceuticals0.6743 of 5 stars$19.00flatN/AN/A$794.77M$285.71M-12.84341Analyst ForecastINZYInozyme Pharma1.8278 of 5 stars$3.32-3.2%N/A-3.0%$213.28MN/A-2.1350ENTAEnanta Pharmaceuticals3.9719 of 5 stars$9.86-2.7%N/A+9.7%$208.93M$79.20M-1.81145Upcoming EarningsENZEnzo Biochem0.2155 of 5 stars$1.03-9.6%N/A-14.8%$53.81M$31.91M0.00520Analyst ForecastAMPHAmphastar Pharmaceuticals4.88 of 5 stars$44.42-1.4%N/A-20.6%$2.14B$644.40M14.811,761Insider SellingEVOEvotec1.0235 of 5 stars$5.51+8.0%N/A-44.7%$1.95B$845.74M0.005,061Short Interest ↓News CoverageGap UpHigh Trading VolumeAKROAkero Therapeutics4.0326 of 5 stars$27.85-6.4%N/A+94.5%$1.94BN/A-7.4330Earnings ReportShort Interest ↓Analyst RevisionNews CoverageCNTACentessa Pharmaceuticals4.0929 of 5 stars$17.00-2.9%N/A+129.2%$1.93B$6.85M-11.1172Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageHRMYHarmony Biosciences4.8494 of 5 stars$32.97-0.1%N/A+28.5%$1.88B$582.02M15.63200Short Interest ↓ Related Companies and Tools Related Companies Aquestive Therapeutics Competitors Intercept Pharmaceuticals Competitors Inozyme Pharma Competitors Enanta Pharmaceuticals Competitors Enzo Biochem Competitors Amphastar Pharmaceuticals Competitors Evotec Competitors Akero Therapeutics Competitors Centessa Pharmaceuticals Competitors Harmony Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TERN) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TERN Stock Alerts